ES2066373T3 - Un proceso para la preparacion de 2(r)-metil-4,4,4-trifluorobutilamina, intermedios, y un proceso para la preparacion de un derivado de la misma. - Google Patents
Un proceso para la preparacion de 2(r)-metil-4,4,4-trifluorobutilamina, intermedios, y un proceso para la preparacion de un derivado de la misma.Info
- Publication number
- ES2066373T3 ES2066373T3 ES91311073T ES91311073T ES2066373T3 ES 2066373 T3 ES2066373 T3 ES 2066373T3 ES 91311073 T ES91311073 T ES 91311073T ES 91311073 T ES91311073 T ES 91311073T ES 2066373 T3 ES2066373 T3 ES 2066373T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- methyl
- butyramide
- derivative
- trifluorobutilamina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
- C07C209/50—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of carboxylic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/18—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Carbon And Carbon Compounds (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
UN PROCESO PARA LA PREPARACION DE (2R)-METIL-4,4,4-TRIFLUOROBUTILIMINA O UNA SAL DE ADICION ACIDA DE LA MISMA QUE CONSISTE EN: A) ACILAR UNA AMINA OPTICAMENTE ACTIVA CON ACIDO 2-METIL-4,4,4 -TRIFLUOROBUTANOICO O CON UN DERIVADO REACTIVO DEL MISMO PARA OBTENER UNA BUTILAMIDA; B) SEPARAR LA BUTIRAMIDA (R)-DISTOMERICA; Y C) CONVERTIR LA BUTIRAMIDA (R)-DIATOMERICA EN LA (2R)-METIL-4,4,4-TRIFLUOROBUTALAMINA DESEADA O EN UNA SAL DE ADICION ACIDA DE LA MISMA. EL PRODUCTO SE PUEDE ACILAR CON UN ACIDO CARBOXILICO QUE TIENE LA FORMULA III EN DONDE U ES CARBOXI O UN DERIVADO REACTIVO DEL MISMO PARA OBTENER (R)-4 [5-(N-[4,4,4-TRIFLUORO-2-METILBUTIL]CARBAMIL)-1-METILINDOL-3-IL-METIL ]-3-METOXI-N-O-COLILSULFONILBENZAMIDA. EL INDOL ES UTIL COMO ANTAGONISTA DE LEUCOTRIENO, EN EL TRATAMIENTO, POR EJEMPLO DEL ASMA O DE LA RINITIS ALERGICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909026425A GB9026425D0 (en) | 1990-12-05 | 1990-12-05 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2066373T3 true ES2066373T3 (es) | 1995-03-01 |
Family
ID=10686507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91311073T Expired - Lifetime ES2066373T3 (es) | 1990-12-05 | 1991-11-29 | Un proceso para la preparacion de 2(r)-metil-4,4,4-trifluorobutilamina, intermedios, y un proceso para la preparacion de un derivado de la misma. |
Country Status (20)
Country | Link |
---|---|
US (1) | US5274118A (es) |
EP (1) | EP0489548B1 (es) |
JP (1) | JP3160041B2 (es) |
AT (1) | ATE115543T1 (es) |
AU (1) | AU649498B2 (es) |
CA (1) | CA2056068C (es) |
CZ (1) | CZ281659B6 (es) |
DE (1) | DE69105931T2 (es) |
DK (1) | DK0489548T3 (es) |
ES (1) | ES2066373T3 (es) |
FI (1) | FI109995B (es) |
GB (1) | GB9026425D0 (es) |
HU (1) | HU212936B (es) |
IE (1) | IE65663B1 (es) |
IL (1) | IL100092A (es) |
NO (1) | NO176516C (es) |
NZ (1) | NZ240857A (es) |
PT (1) | PT99684B (es) |
SK (1) | SK280473B6 (es) |
ZA (1) | ZA919572B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
GB9026427D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Chemical process |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
WO2005005648A1 (ja) * | 2003-07-11 | 2005-01-20 | Mitsubishi Pharma Corporation | 新規な光学活性カルボン酸の製造法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2243977A (en) * | 1938-07-18 | 1941-06-03 | Sandoz Ltd | Process for the preparation of amino-alcohols |
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
US5105014A (en) * | 1991-08-06 | 1992-04-14 | Mallinckrodt Medical, Inc. | Synthesis of vicinal diamines |
-
1990
- 1990-12-05 GB GB909026425A patent/GB9026425D0/en active Pending
-
1991
- 1991-11-19 IL IL10009291A patent/IL100092A/en active IP Right Grant
- 1991-11-22 CA CA002056068A patent/CA2056068C/en not_active Expired - Fee Related
- 1991-11-29 DK DK91311073.0T patent/DK0489548T3/da active
- 1991-11-29 EP EP91311073A patent/EP0489548B1/en not_active Expired - Lifetime
- 1991-11-29 ES ES91311073T patent/ES2066373T3/es not_active Expired - Lifetime
- 1991-11-29 DE DE69105931T patent/DE69105931T2/de not_active Expired - Fee Related
- 1991-11-29 AT AT91311073T patent/ATE115543T1/de not_active IP Right Cessation
- 1991-12-02 HU HU913758A patent/HU212936B/hu not_active IP Right Cessation
- 1991-12-04 SK SK3687-91A patent/SK280473B6/sk unknown
- 1991-12-04 IE IE421991A patent/IE65663B1/en not_active IP Right Cessation
- 1991-12-04 ZA ZA919572A patent/ZA919572B/xx unknown
- 1991-12-04 NZ NZ240857A patent/NZ240857A/xx not_active IP Right Cessation
- 1991-12-04 AU AU88385/91A patent/AU649498B2/en not_active Ceased
- 1991-12-04 US US07/803,291 patent/US5274118A/en not_active Expired - Fee Related
- 1991-12-04 PT PT99684A patent/PT99684B/pt not_active IP Right Cessation
- 1991-12-04 CZ CS913687A patent/CZ281659B6/cs not_active IP Right Cessation
- 1991-12-04 FI FI915721A patent/FI109995B/fi not_active IP Right Cessation
- 1991-12-04 NO NO914776A patent/NO176516C/no unknown
- 1991-12-05 JP JP32180191A patent/JP3160041B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2056068C (en) | 2003-05-06 |
EP0489548B1 (en) | 1994-12-14 |
DK0489548T3 (da) | 1995-05-08 |
NO914776L (no) | 1992-06-09 |
HU212936B (en) | 1996-12-30 |
IE65663B1 (en) | 1995-11-15 |
NO176516C (no) | 1995-04-19 |
CS368791A3 (en) | 1992-09-16 |
HUT61964A (en) | 1993-03-29 |
EP0489548A1 (en) | 1992-06-10 |
PT99684A (pt) | 1992-10-30 |
DE69105931T2 (de) | 1995-05-04 |
NO914776D0 (no) | 1991-12-04 |
FI915721A0 (fi) | 1991-12-04 |
CA2056068A1 (en) | 1992-06-06 |
AU8838591A (en) | 1992-06-11 |
NZ240857A (en) | 1994-05-26 |
AU649498B2 (en) | 1994-05-26 |
FI915721A (fi) | 1992-06-06 |
IL100092A (en) | 1996-10-16 |
CZ281659B6 (cs) | 1996-12-11 |
DE69105931D1 (de) | 1995-01-26 |
GB9026425D0 (en) | 1991-01-23 |
HU913758D0 (en) | 1992-02-28 |
ZA919572B (en) | 1992-10-28 |
IL100092A0 (en) | 1992-08-18 |
ATE115543T1 (de) | 1994-12-15 |
JP3160041B2 (ja) | 2001-04-23 |
FI109995B (fi) | 2002-11-15 |
IE914219A1 (en) | 1992-06-17 |
SK280473B6 (sk) | 2000-02-14 |
US5274118A (en) | 1993-12-28 |
PT99684B (pt) | 1999-05-31 |
JPH04290870A (ja) | 1992-10-15 |
NO176516B (no) | 1995-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU90160I2 (fr) | Naratriptan facultativement sous la forme d'un sel pharmaceutiquement acceptable ou d'un solvate y compris le chlorhydrate de naratriptan | |
FI904118A0 (fi) | Parannettu menetelmä trans-6-/2-(substituoitu pyrrol-1-yyli)alkyyli/pyran-2-onien valmistamiseksi | |
PL302163A1 (en) | Novel derivatives of benzimidazolone | |
NZ235323A (en) | Amide derivatives and pharmaceutical compositions thereof | |
HUP9602685A2 (hu) | Helyettesített kinolin-2-karbonsav-amidok, eljárás előállításukra és alkalmazásuk gyógyszerekként, valamint közbenső termékek | |
EA200200114A1 (ru) | Амиды карбоновой кислоты, содержащие эти соединения лекарственные средства, их применение и получение | |
EP0926131A3 (de) | Verfahren zur Herstellung von Aminoalkoholderivaten und deren Weiterumsetzung zu (1R,4S)-4-((2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino)-2-cyclopenten-1-methanol | |
GR3032220T3 (en) | Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation | |
GEP19971017B (en) | Process of preparation of benzocycloalkenyldihydroxyalkanoic acids derivatives | |
ES2066373T3 (es) | Un proceso para la preparacion de 2(r)-metil-4,4,4-trifluorobutilamina, intermedios, y un proceso para la preparacion de un derivado de la misma. | |
MA21902A1 (fr) | Procede pour la preparation de peptitides hemoregulateurs et des compositions pharmaceutiques les comtenant . | |
ATE184793T1 (de) | Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8 | |
FI103046B1 (fi) | Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi | |
EP1134213A3 (en) | Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides | |
DE69716447D1 (de) | Neu klebstoffe auf cyanoacrylatbasis, verfahren zu deren herstellung und verwendungen | |
FI102748B1 (fi) | Menetelmä N-(2,6-dialkyylifenyyli)-2-(2-okso-1-pyrrolidinyyli)asetamidijohdannaisen valmistamiseksi | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
CA2418227A1 (en) | Process for the preparation of 5-hydroxymethyl 2-oxazolidinone and novel intermediate | |
KR920012030A (ko) | 약학적 중간 물질의 제조방법 | |
NZ244870A (en) | Preparative process for 2-c -c alk-1-en-1-ylbenzenesulphonic acid n-[4-(5-cyclopentyloxyamino-1-methylindol-3-ylmethyl)-3-methoxybenzoy l]amides;dicyclopentyl dicarbonate as acylating agent | |
EP1170287A4 (en) | PROCESS FOR THE PREPARATION OF N OPTICALLY ACTIVE SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 489548 Country of ref document: ES |